Literature DB >> 32884634

Getting the best out of faecal immunochemical tests and faecal calprotectin.

Charlotte Chuter1, Ada Keding2, Hayden Holmes3, Daniel Turnock4, James Turvill1.   

Abstract

Keywords:  IBD clinical; clinical decision making; colorectal cancer; decision analysis; irritable bowel syndrome

Year:  2019        PMID： 32884634      PMCID： PMC7447280          DOI： 10.1136/flgastro-2019-101381

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  8 in total

1.  Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.

Authors:  James Turvill; Samantha Mellen; Laura Jeffery; Sarah Bevan; Ada Keding; Daniel Turnock
Journal:  Scand J Gastroenterol       Date:  2019-01-08       Impact factor: 2.423

2.  Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.

Authors:  James Turvill; Assad Aghahoseini; Nala Sivarajasingham; Kazim Abbas; Murtaza Choudhry; Kostantinos Polyzois; Kostantinos Lasithiotakis; Dimitra Volanaki; Baek Kim; Fiona Langlands; Helen Andrew; Jesper Roos; Samantha Mellen; Daniel Turnock; Alison Jones
Journal:  Br J Gen Pract       Date:  2016-06-06       Impact factor: 5.386

3.  Evaluation of a faecal calprotectin care pathway for use in primary care.

Authors:  James Turvill; Shaun O'Connell; Abigail Brooks; Karen Bradley-Wood; James Laing; Swaminathan Thiagarajan; David Hammond; Daniel Turnock; Alison Jones; Ruchit Sood; Alex Ford
Journal:  Prim Health Care Res Dev       Date:  2016-02-22       Impact factor: 1.458

4.  High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal disease.

Authors:  James Turvill
Journal:  Frontline Gastroenterol       Date:  2011-09-19

5.  Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.

Authors:  Ian M Godber; Louise M Todd; Callum G Fraser; Linda R MacDonald; Hakim Ben Younes
Journal:  Clin Chem Lab Med       Date:  2016-04       Impact factor: 3.694

6.  Low faecal haemoglobin concentration potentially rules out significant colorectal disease.

Authors:  P J McDonald; J Digby; C Innes; J A Strachan; F A Carey; R J C Steele; C G Fraser
Journal:  Colorectal Dis       Date:  2013-03       Impact factor: 3.788

7.  Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.

Authors:  Craig Mowat; Jayne Digby; Judith A Strachan; Robyn Wilson; Francis A Carey; Callum G Fraser; Robert J C Steele
Journal:  Gut       Date:  2015-08-20       Impact factor: 23.059

8.  Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care Pathway.

Authors:  James Turvill; Daniel Turnock; Hayden Holmes; Alison Jones; Eleanor Mclaughlan; Victoria Hilton; Stacey Marriott
Journal:  Frontline Gastroenterol       Date:  2018-06-07
  8 in total
  1 in total

Review 1.  Biomarkers to Detect Early-Stage Colorectal Cancer.

Authors:  Jacqueline I Keenan; Frank A Frizelle
Journal:  Biomedicines       Date:  2022-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.